A few years ago..When Bellus bought TLN and joined their existing ongoing project Kiacta's already on stage 3
testing , there was a high hope this drug might suceed. However it turned out to be the opposite.
Things went down like a chute of falling water. Sp drop from 3$ to a few cents. The Shigamab
bought from TLN still in the developement phase to find another drugs for many years already.
I was a bit disappointed becasue I had high hope that may be one day we will see the light. I am still
hoping the undergoing drug program might work that is why after so many years of absence I start
back back some shares. I hope I will run into some former shareholder of TLN, and new shareholders exchanging our views for this new company. Go luck to all shareholders who still
have faith in this company.